Wood D E, Raghu G
Section of General Thoracic Surgery, University of Washington School of Medicine, Seattle 98195, USA.
West J Med. 1996 Dec;165(6):355-63.
In the past 8 years, lung transplantation has become a standard therapy for benign end-stage pulmonary disease. Rapid advances have occurred involving indications and operative management that have allowed pulmonary transplantation to be a viable option for an increasingly diverse patient population. In part I, we review the current indications and operative techniques, and in part II we will cover the postoperative management and results.
在过去8年里，肺移植已成为良性终末期肺病的标准治疗方法。在适应证和手术管理方面取得了快速进展，这使得肺移植对于越来越多不同类型的患者群体而言成为了一个可行的选择。在第一部分，我们将回顾当前的适应证和手术技术，在第二部分我们将阐述术后管理及结果。
